Navigating the Neurodegenerative Crisis: A Multifaceted Approach
Overtaking more established issues like cancer and heart disease, neurological problems have become a major worldwide health concern.
December 9, 2024
by Shruti Talashi
Immunoconjugates: Biological Missiles for Diagnosis and Treatment
Immunoconjugates already play an important role in the treatment of cancer, and their role is likely to expand into other therapeutic indications.
August 2, 2024
by Suzanne Elvidge
Research Progress in the Treatment of Refractory Mycoplasma Pneumoniae Pneumonia
Currently, the main clinical treatment methods for refractory Mycoplasma pneumoniae pneumonia (RMPP) after diagnosis include bronchoscope lavage, antibiotic therapy, glucocorticoid therapy, immune modulation treatment, antithrombotic therapy, and integrat
June 25, 2024
by Xiaomichong
COPD Treatment Landscape
The comprehensive management of Chronic Obstructive Pulmonary Disease (COPD) requires a multi-faceted approach encompassing medications, lifestyle adjustments, and surgical interventions.
January 19, 2024
by David Orchard-Webb
Postop Anxiety During Care Transitions Reduced With Peer Mentoring
Mentoring programs can help improve patients' transition from hospital to home by reducing...
January 28, 2022
by drugs.com
FDA Grants Emergency Use Authorization for Pfizer's Paxlovid Pill as First At-Home COVID-19 Treatment
he U.S. Food and Drug Administration on Wednesday approved the emergency use of Pfizer's new antiviral pill Paxlovid in people who are at high risk for severe COVID-19. It's the first approved treatment for COVID-19 meant to be taken at home.
December 22, 2021
by drugs
Evive Biotech meets primary and secondary endpoints in global Phase III clinical trial for their novel chemotherapy-induced neutropenia treatment
Evive Biotech, a global biologics company developing novel biological therapies, is delighted to announce that its pivotal Phase III study (NCT03252431) for F-627 (efbemalenograstim alpha) to treat chemotherapy-induced neutropenia (CIN) in breast cancer
July 8, 2020
by prnasia
Vice-premier stresses research on COVID-19 vaccine, treatment, medicine
Vice-Premier Sun Chunlan on April 1 stressed making full use of the effective drugs and treatment technologies and accelerating the progress of vaccine research and development to fight the novel coronavirus disease (COVID-19).
April 4, 2020
by chinadaily
FDA continues to facilitate development of COVID-19 treatments
The U.S. Food and Drug Administration continues to play a critical role in the multifaceted all-of-government response to the COVID-19 pandemic.
March 23, 2020
by worldpharmanews
Coronavirus (COVID-19) Update: FDA Continues to Facilitate Development of Treatments
The U.S. Food and Drug Administration continues to play a critical role in the multifaceted all-of-government response to the COVID-19 pandemic.
March 20, 2020
by prnewswire
Pharma and Biotech Review: Treatment Options for COVID-19: Decoding the Latest Developments
The Coronavirus Disease 2019 (COVID-19), which emerged in Wuhan, a city of 11 million in Hubei province, has spread to more than two dozen countries, taking the lives of more than 2,800 people.
March 11, 2020
by Neeta Ratanghayra
High-dose Erythropoietin No Benefit for Extreme Preemies
For extremely preterm infants, high-dose erythropoietin treatment from 24 hours after birth does not result in a reduced risk for severe neurodevelopmental impairment or death at age 2 years ...
January 20, 2020
by drugs